Current UK guidelines allow surgeons who are antibody-positive for hepatiti
s C virus (HCV) to continue performing exposure-prone procedures (EPPs) unl
ess they have been shown to transmit HCV to a patient. Given the low rate o
f recognised transmission from surgeon to patient, this recommendation is p
robably reasonable and is consistent with the management of eAg negative ca
rriers of hepatitis B who are also allowed to continue operating. It seems
likely that, in the future, pressure will increase to remove surgeons who a
re HCV-positive (or positive for HBsAg without HBeAg or HIV-positive) from
the list of those able to perform EPPs. If implemented, this would require
surgeons to be tested at regular intervals for HCV status. There are no dat
a to demonstrate that such an approach would benefit patients overall and t
he ethical costs would be high because many surgeons will have acquired HCV
occupationally. The financial costs would also be high and, in my opinion,
would be better deployed by ensuring that existing simple preventative mea
sures are routinely applied to prevent patient-surgeon-patient transmission
of all blood-borne viruses. Copyright (C) 2000 John Wiley & Sons, Ltd.